Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Hum Mutat ; 41(5): 906-912, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-31930626

RESUMEN

Next-generation sequencing (NGS) is helpful in diagnosing complex genetic disorders and phenotypes, particularly when more than one overlapping condition is present. From a large cohort of 362 families with clinical manifestations of skin and mucosal fragility, referred by several major medical centers, one patient was found by NGS to have two overlapping heritable skin diseases, recessive dystrophic epidermolysis bullosa (RDEB; COL7A1 mutations) and acrodermatitis enteropathica (AE; SLC39A4 mutations). The pathogenicity of the variants was studied at gene expression as well as ultrastructural and tissue levels. Although there is no specific treatment for RDEB except avoiding trauma, supplementation with oral zinc (3 mg·kg-1 ·day-1 ) for the AE resulted in rapid amelioration of the skin findings. This case demonstrates the power of NGS in identifying two genetically unlinked diseases that led to effective treatment with major clinical benefits as an example of genomics-guided treatment.


Asunto(s)
Acrodermatitis/genética , Acrodermatitis/terapia , Epidermólisis Ampollosa/genética , Epidermólisis Ampollosa/terapia , Predisposición Genética a la Enfermedad , Genómica , Zinc/deficiencia , Acrodermatitis/diagnóstico , Adolescente , Alelos , Biomarcadores , Biopsia , Proteínas de Transporte de Catión , Toma de Decisiones Clínicas , Colágeno Tipo VII/genética , Consanguinidad , Manejo de la Enfermedad , Epidermólisis Ampollosa/diagnóstico , Femenino , Genómica/métodos , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Mutación , Linaje , Fenotipo , Piel/patología
2.
J Pediatr Hematol Oncol ; 29(4): 233-8, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17414565

RESUMEN

PURPOSE: To determine the prevalence and geographic distribution of thalassemia and to evaluate the success of the thalassemia prevention and treatment programs in Iran. METHODS: Data were obtained from the National Thalassemia Registry of Iran, Iranian Blood Transfusion Organization, genetic laboratories involved in prenatal diagnosis, related pharmaceutical companies, and centers performing bone marrow transplantation for thalassemic patients. RESULTS: A total of 13,879 living patients have been registered, mostly from the northern and southern parts of Iran with the median age of 15 years. Twenty-three percent of patients were older than 20 years. The number of newly diagnosed cases has been decreased considerably after the start of the prevention program. Since the introduction of prenatal diagnosis, 2819 couples (2549 fetuses) have been tested, with only 6 false results. Elective abortion was not performed in 10 affected fetuses. Most common mutations detected were IVS II-1 and IVS I-5. In 2003, approximately 25% of the national blood products and 6 million vials of desferal were used for thalassemic patients. Overall, 340 patients have received allogeneic bone marrow transplantation, of those 46 patients deceased. Bloodborne infections have also been decreased significantly owing to the national screening of blood products for bloodborne viral infections. DISCUSSION: Owing to the national prevention program and provided special care, the age distribution of thalassemic patients in Iran is getting adapted to a full prevention and treatment program and life expectancy of these patients has been increased considerably. This shift in the age distribution of thalassemia, a traditionally considered pediatric disease, will face us with new challenges and the health care system should be prepared for this new face of thalassemia.


Asunto(s)
Talasemia/epidemiología , Talasemia/prevención & control , Talasemia/terapia , Aborto Inducido , Adolescente , Adulto , Trasplante de Médula Ósea , Femenino , Humanos , Irán , Masculino , Programas Nacionales de Salud , Embarazo , Diagnóstico Prenatal , Prevalencia , Sistema de Registros , Talasemia/diagnóstico , Talasemia/genética , Trasplante Homólogo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA